reconstituted refrigerated at 28 C (35.646.4 F) for up to 4 weeks [16]
GLP-1 receptor agonists have transformed the management of obesity and type 2 diabetes in recent years
Emerging studies from his team and others show GLP-1 agonists may improve nerve conduction velocity (NCV) suggesting a potential benefit for nerve health
Options your provider may consider include extending the time between dose increases to give your gut more time to adapt, temporarily reducing the dose until constipation management strategies take effect, or switching between GLP-1 medications if one produces intolerable side effects
However, based on its mechanism of action and related drug classes, several precautions are considered relevant: Hypersensitivity: Individuals with known hypersensitivity to Retatrutide or any peptide excipients should avoid exposure
As with other incretin-based therapies, retatrutide has been associated with a range of side effects in clinical trials